Web portals

A signpost to further relevant information on innovative therapies for the general and professional public.

Events and news

Discovery of a New Molecular Cause of a Neurodevelopmental Disorder from the Group of DNA Remodeling Defects.

DNA remodelling disorders are a rapidly expanding group of rare monogenic diseases. Common features of these conditions include de-novo heterozygous causative variants in key genes/proteins involved in DNA and histone modification pathways, as well as highly variable clinical phenotypes encompassing developmental and functional abnormalities affecting multiple organs, particularly the nervous and cranioskeletal systems.

A new perspective on the early phase of Alzheimer’s disease: Changes in the protective tau protein disrupt cytoskeletal protection and enable its degradation

In the early stages of Alzheimer’s disease, changes occur in a key protein called tau, which normally forms a protective layer around the neuron’s internal skeleton. When modified, tau loses its protective function, leading to neuron death. The new perspective presented by a Czech-French research team uncovers the molecular consequences of tau modifications, opening new avenues for the diagnosis and treatment of early-stage Alzheimer’s disease and related disorders.